• Mashup Score: 4
    FLOWER-MI and the root of the problem with non-culprit revascularisation - 2 year(s) ago

    How do we reduce cardiac death and myocardial infarction by percutaneous coronary intervention (PCI) in coronary heart disease? Although the interventional community continues to grapple with this question in stable angina, the benefits of PCI for non-culprit lesions found at ST-elevation myocardial infarction are established. Is it then wishful thinking that an index developed in stable coronary…

    Source: Open Heart
    Categories: Cardiology News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of Open_HeartBMJ
      Open_HeartBMJ

      FLOWER-MI & root of the problem with non-culprit revascularisation @mattlkw @K_DeSilva @ColletCarlos @divaka_perera #OpenHeartBMJ #FLOWERMI https://t.co/E6UAWsrtrx https://t.co/mtxc6d8PVd

  • Mashup Score: 3
    ACC 2021: What Could Change UK Cardiology Practice? - 3 year(s) ago

    Dr Sukh Nijjer highlights five important studies presented to the American College of Cardiology (ACC) 2021 Scientific Session.

    Source: Medscape
    Categories: Cardiologists, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of SukhNijjer
      SukhNijjer

      What were your Top 5 studies from #ACC21? How are you going to change your #Cardiology practice? Watch a brief @Medscape @theheartorg overview of #LAAOSIII, #FlowerMI #HOSTExam #PARADISEMI and #RADIANCEHTN. Some clear messages & some caution. https://t.co/vVb1blP8cp

  • Mashup Score: 4
    ESC Expert Insights at ACC 2021 - 3 year(s) ago

    Your access to the latest cardiovascular news, science, tools and resources.

    Source: www.escardio.org
    Categories: Cardiology News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of escardio
      escardio

      .@escardio Expert Insights From #PARADISEMI, #FLOWERMI LAAOS III to ATLANTIS, ADAPTABLE, RADIANCE-HTN-TRIO and more, ESC experts bring you key messages from 17 trials & trial updates presented during #ACC21 and the impact of these on clinical practice https://t.co/b5k12KBa4r https://t.co/epKVVnDLiU